False Positives on Mammograms: What They Mean and What to Do

Getting a call from your doctor's office saying your mammogram showed something that needs a closer look is stressful. But before jumping to worst-case conclusions, it helps to understand that false positives, findings that initially look concerning but turn out not to be cancer, are a normal and expected part of breast cancer screening.

How Common Are False Positives?

False positives are far more common than most women realize. In the United States, approximately 10 to 12 percent of women who undergo a screening mammogram are called back for additional imaging. After that additional workup, the vast majority are cleared. Only about 4 to 5 percent of women called back will ultimately need a biopsy, and of those biopsied, roughly 20 to 30 percent will be diagnosed with cancer.

Putting this in perspective: for every 1,000 women screened, about 100 to 120 will be recalled, 40 to 50 will undergo biopsy, and 5 to 10 will be diagnosed with cancer. The remaining 90-plus women who were called back will ultimately receive good news.

Over a 10-year period of annual screening, the cumulative probability of receiving at least one false-positive result is about 50 percent. With biennial (every two years) screening, that figure drops to roughly 25 percent. This is one reason some organizations recommend biennial rather than annual screening for average-risk women.

Why False Positives Happen

Several factors contribute to false-positive results:

Dense Breast Tissue

Women with heterogeneously dense or extremely dense breasts have higher false-positive rates. Dense tissue can obscure or mimic the appearance of masses, making it harder for radiologists to determine whether a finding is a true abnormality or just overlapping normal tissue.

No Prior Images for Comparison

First-time mammograms have significantly higher callback rates because the radiologist has no prior images to compare against. When there is no baseline, any finding that could potentially represent an abnormality must be investigated. Once you have established a screening history, the radiologist can compare year-over-year images and more confidently identify stable, benign findings.

Hormone Use

Women taking hormone replacement therapy (HRT), particularly combined estrogen-progestin formulations, tend to have denser breast tissue and higher false-positive rates. A study in the Journal of the National Cancer Institute found that current HRT users had a 17% higher recall rate compared to non-users.

Individual Radiologist Variation

Radiologists vary in their threshold for calling patients back. This is sometimes referred to as the "audit rate." Radiologists with lower recall rates may miss more cancers but generate fewer false positives, while those with higher recall rates catch more cancers but also produce more false alarms. The American College of Radiology recommends a recall rate between 5 and 12 percent for screening mammograms.

What Happens During a Callback

If you are called back, the facility will schedule a diagnostic mammogram appointment. This is different from a screening mammogram in several ways:

• A radiologist is typically present or immediately available to review images in real time.
• Additional views may be taken, including spot compression (magnified images of a specific area) and rolled views.
• Ultrasound may be performed during the same visit if the mammogram findings warrant it.
• You will often receive results before you leave the facility, rather than waiting days.

In many cases, the additional imaging will show that the original finding was nothing more than overlapping normal tissue, a benign cyst, or a stable calcification. You will be told to return for routine screening in one year.

If a Biopsy Is Recommended

If the diagnostic workup does not resolve the finding, a biopsy may be recommended. The most common type is a core needle biopsy, which uses a hollow needle to extract small samples of tissue. It is typically performed under image guidance (ultrasound or stereotactic mammography) and done as an outpatient procedure with local anesthesia.

The procedure takes about 15 to 30 minutes. Most women describe the biopsy itself as involving pressure rather than sharp pain. Mild bruising and tenderness at the biopsy site are normal and usually resolve within a few days. Results are typically available within three to five business days.

The Emotional Impact

Research consistently shows that false-positive mammograms cause significant short-term anxiety. A study published in the Annals of Family Medicine found that women who experienced a false positive reported elevated anxiety levels that persisted for up to three months after the issue was resolved. However, the same research found that the experience did not deter most women from continuing to participate in screening.

If you find the waiting period difficult, it can help to ask the facility about their expected timeline for results and to identify a specific person you can contact if you have not heard back within that window. Having a plan reduces the feeling of uncertainty.